Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 23.58M P/E - EPS this Y 350.90% Ern Qtrly Grth -
Income 8.13M Forward P/E -30.00 EPS next Y 45.50% 50D Avg Chg -5.00%
Sales 131.44M PEG - EPS past 5Y - 200D Avg Chg -34.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -59.00%
Recommedations - Quick Ratio 1.18 Shares Outstanding 16.29M 52W Low Chg 50.00%
Insider Own - ROA 17.01% Shares Float - Beta 1.89
Inst Own - ROE 126.37% Shares Shorted/Prior -/- Price 1.80
Gross Margin 94.73% Profit Margin 6.18% Avg. Volume 1,779 Target Price 24.25
Oper. Margin 11.84% Earnings Date Nov 11 Volume 5,406 Change 0.00%
About BIOSTEM TECHNOLOGIES INC

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

BIOSTEM TECHNOLOGIES INC News
11/20/24 BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
11/15/24 BSEM: Medicare Issues Shouldn’t Impact BioStem
11/13/24 BSEM Continues to Exceed Expectations
11/12/24 BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
10/29/24 BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
10/28/24 BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
06:00 AM BioStem Technologies to Present at the LD Micro Main Event XVII on Wednesday, October 30, 2024, at 9:30 AM PT
10/17/24 BSEM Announces Expanding Market and Stellar Test Results
10/17/24 BioStem Technologies Reports Breakthrough Results in a Diabetic Foot Ulcer Wound Closure Study Comparing BioREtain® to Standard of Care Treatment
10/15/24 BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
10/02/24 BSEM Initiates Trial and Start Uplisting Process
10/02/24 BioStem Technologies Initiates BR-AC-DFU-101 Clinical Trial to Study BioREtain® in Diabetic Foot Ulcers
09/30/24 BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for Uplisting
08/29/24 BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
08/21/24 BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
08/13/24 BSEM Revenues are Growing Exponentially
08/12/24 BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
08/05/24 BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
07/16/24 BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments
07/10/24 BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers
BSEM Chatroom

User Image johnnyo_44 Posted - 24 minutes from now

$BSEM https://nypost.com/2024/11/23/opinion/donald-trump-picks-dr-oz-for-medicare-services-letters/

User Image IRISHMIKE1 Posted - 7 hours ago

$BSEM It Dod, It Did! My order filled and price went up? So, I’m Green and can sit on this and wait for listing and increased revenue! Like sitting on a Gold Mine. You know the value is there and increasing daily just waiting for it to come out!! 😂

User Image IRISHMIKE1 Posted - 1 day ago

$BSEM ok, coming to end of day! Let my order fill!!

User Image IRISHMIKE1 Posted - 1 day ago

$BSEM Nack up $14 and continuing back up to $20’s!!

User Image IRISHMIKE1 Posted - 2 days ago

$BSEM Absolutely! Way oversold, but Nice! I was able to buy more on Sale! Got a bunch yesterday at $11.70! I knew it was super cheap! I have been saying that Listing on NASDAQ will be GOOD for the Company and the SP !! Nice ReBOUND!

User Image slem7 Posted - 2 days ago

$BSEM The sell-down was overdone. Nice rebound. DCA is the play. Uplisting will qualify the stock for greater market participation. The opportunity is now!

User Image IRISHMIKE1 Posted - 3 days ago

$BSEM well sitting tight today before buying more. Let’s see how this shakes out?

User Image GlobalInsights Posted - 3 days ago

$BSEM Just think a week ago you could have sold this for $28.

User Image prismmarketview Posted - 3 days ago

$BSEM https://prismmarketview.com/biostem-technologies-seeks-to-expand-wound-care-portfolio-with-letter-of-intent-to-acquire-progenacare-products/

User Image johnnyo_44 Posted - 3 days ago

$BSEM anyone know anything about the company being acquired?

User Image Biotech_rabi Posted - 3 days ago

$BSEM https://www.globenewswire.com/news-release/2024/11/20/2984274/0/en/BioStem-Technologies-Signs-Letter-of-Intent-to-Acquire-Wound-Care-Products-and-Technologies-from-ProgenaCare-Global.html

User Image IRISHMIKE1 Posted - 4 days ago

$BSEM ouch, not sure why it continues to drop. The initial release that it product was approved for reimbursement did not cause sp to go up very much. So if delayed should not cause such a big drop!

User Image GlobalInsights Posted - 4 days ago

$BSEM Seems on a trajectory to $10?

User Image IRISHMIKE1 Posted - 4 days ago

$BSEM Tomorrow, market rebounds and so does BSEM!

User Image IRISHMIKE1 Posted - 5 days ago

$BSEM Here we go on the way UP!! ⬆️

User Image Zer0_Antiseptic Posted - 5 days ago

$BSEM why are you posting outdated analysis from before the November 14 LCD? Check their NASDAQ uplisting documents. "As proposed, the LCDs would eliminate Medicare coverage for our products absent the development of acceptable published, peer-reviewed evidence. Currently, management cannot determine the timing of when, if any, decision will be made on the proposed LCDs. "

User Image Finanz Posted - 5 days ago

$BSEM https://scr.zacks.com/news/news-details/2024/BSEM-Continues-to-Exceed-Expectations/default.aspx

User Image ja1234567 Posted - 5 days ago

$BSEM the fact is they are right about not having coverage starting 2/12/25 for any of their products. On the other side of the argument it could get reversed or compromised.

User Image johnnyo_44 Posted - 5 days ago

$BSEM gotta love when someone creates an account today to provide is with some expert information…trying to get that stock to go lower for ya??? See the post below

User Image Zer0_Antiseptic Posted - 5 days ago

$BSEM the November 14 Local Coverage Determination has Vendaje and Amniowrap2 as Non-Covered Products starting in February. The CMS website says the retrospective studies will not be considered for coverage. Those clinical trials they just started last month will take about a year to finish, there is a serious risk that come February their revenues will be severely impacted. Medicare is paying out billions to skin substitute companies so they are trying to get this policy in place sooner rather than later. The odds that they can successfully lobby against the LCD seem pretty grim. Either way it is a massive risk for investors here.

User Image IRISHMIKE1 Posted - 6 days ago

$BSEM Actually risk is a lot lower then ever after Friday ridiculous sell off.

User Image johnnyo_44 Posted - 6 days ago

$BSEM https://finance.yahoo.com/news/bsem-medicare-issues-shouldn-t-160500411.html

User Image GlobalInsights Posted - 1 week ago

$BSEM Looks like you will be able to pick this up under $10

User Image GlobalInsights Posted - 1 week ago

$BSEM Wow, just think, you could have sold for $28 three days ago. Could be a couple of yrs before it hits that again. The most successful investors are the ones that don’t loose what they already gained! I learned that over and over the hard way!

User Image spscorpion Posted - 1 week ago

$BSEM there’s something weird going on. Had to close the entire position. Shoot first ask questions later. $11/Share is the next catch

User Image osubuck30 Posted - 1 week ago

$BSEM cut my position by 75%. Risk is a lot higher. Took my 50% plus gain here.

User Image GlobalInsights Posted - 1 week ago

$BSEM $28 to $15 in 3 days must be unnerving for the neophyte’s investing in this thing. I would expect a rather large decline in revenue once the LCD actions are taken. So until then a smart investor might want to trade this thing instead of holding for the long term.

User Image IRISHMIKE1 Posted - 1 week ago

$BSEM yes we are dropping but I love it. Don’t get me wrong long term I expect to make money!! My avg is less then $10so I am looking at recent drop to buy more shares!! I know with last earnings we are not going down to where I originally bought.

User Image GmanPA Posted - 1 week ago

$BSEM Did they get CMS (Medicaid and Medicare) approval? Someone else said no. Any details on that? Info appreciated.

User Image IRISHMIKE1 Posted - 1 week ago

$BSEM huge revenue increase. Great future Guidance! About to go on Nasdaq and price drops?? Lol, manipulation so someone can get shares cheap and RIDE the TRAIN UP AS WE GO UP!!

Analyst Ratings
Zacks Investment Research Buy Nov 7, 22